How would you approach a patient with recurrent uterine adenosarcoma with sarcomatous overgrowth following R0 resection of secondary pelvic tumor debulking?
Patient has previously received two lines of systemic therapy (gemcitabine + docetaxel + bevacizumab and ifosfamide + doxorubicin) and whole pelvic radiation therapy. Tumoral testing without any targeted therapy options.
Community PollStarted
How would you approach a patient with recurrent uterine adenosarcoma with sarcomatous overgrowth following R0 resection of secondary pelvic tumor debulking?
4 physicians have voted
Join Mednetto vote and see how they answered.